Use Of Il-33 Antagonists To Treat Fibrotic Disease

Patent No. EP2475388 (titled "Use Of Il-33 Antagonists To Treat Fibrotic Disease") was filed by Merck Sharp & Dohme on Sep 1, 2010. The application was issued on Nov 8, 2017.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ELI LILLYAug 8, 2018KENT

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP2475388

MERCK SHARP & DOHME
Application Number
EP10815921A
Filing Date
Sep 1, 2010
Status
Opposition Rejected
Mar 27, 2020
Publication Date
Nov 8, 2017